Xylem Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Xylem wird ein jährliches Gewinn- und Umsatzwachstum von 15.9% bzw. 6.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 15.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.8% betragen.

Wichtige Informationen

14.5%

Wachstumsrate der Gewinne

14.9%

EPS-Wachstumsrate

Machinery Gewinnwachstum9.2%
Wachstumsrate der Einnahmen5.1%
Zukünftige Eigenkapitalrendite11.2%
Analystenabdeckung

Good

Zuletzt aktualisiert13 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Xylem (NYSE:XYL) Could Easily Take On More Debt

Aug 15
Xylem (NYSE:XYL) Could Easily Take On More Debt

Do Xylem's (NYSE:XYL) Earnings Warrant Your Attention?

Jul 31
Do Xylem's (NYSE:XYL) Earnings Warrant Your Attention?

Calculating The Fair Value Of Xylem Inc. (NYSE:XYL)

Jul 17
Calculating The Fair Value Of Xylem Inc. (NYSE:XYL)

What You Can Learn From Xylem Inc.'s (NYSE:XYL) P/E

Jul 04
What You Can Learn From Xylem Inc.'s (NYSE:XYL) P/E

Xylem: Wait For Multiple Contraction For This Excellent Company

Jun 21

Is Now The Time To Look At Buying Xylem Inc. (NYSE:XYL)?

May 23
Is Now The Time To Look At Buying Xylem Inc. (NYSE:XYL)?

There May Be Underlying Issues With The Quality Of Xylem's (NYSE:XYL) Earnings

May 10
There May Be Underlying Issues With The Quality Of Xylem's (NYSE:XYL) Earnings

Is Xylem (NYSE:XYL) Using Too Much Debt?

May 07
Is Xylem (NYSE:XYL) Using Too Much Debt?

Is Now The Time To Put Xylem (NYSE:XYL) On Your Watchlist?

Apr 24
Is Now The Time To Put Xylem (NYSE:XYL) On Your Watchlist?

Xylem: Bigger Does Not Mean Better Shareholder Value

Apr 04

With Xylem Inc. (NYSE:XYL) It Looks Like You'll Get What You Pay For

Mar 28
With Xylem Inc. (NYSE:XYL) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of Xylem Inc. (NYSE:XYL)

Mar 14
Calculating The Fair Value Of Xylem Inc. (NYSE:XYL)

Xylem: Fund Managers Like This Top ESG-Rated Stock

Jan 22

Should You Think About Buying Xylem Inc. (NYSE:XYL) Now?

Dec 12
Should You Think About Buying Xylem Inc. (NYSE:XYL) Now?

Xylem: Good Prospects, But Pricey

Nov 09

With EPS Growth And More, Xylem (NYSE:XYL) Makes An Interesting Case

Nov 09
With EPS Growth And More, Xylem (NYSE:XYL) Makes An Interesting Case

Xylem: Overvalued Stock Despite An Interesting Merger

Oct 24

Estimating The Fair Value Of Xylem Inc. (NYSE:XYL)

Oct 24
Estimating The Fair Value Of Xylem Inc. (NYSE:XYL)

These 4 Measures Indicate That Xylem (NYSE:XYL) Is Using Debt Reasonably Well

Sep 12
These 4 Measures Indicate That Xylem (NYSE:XYL) Is Using Debt Reasonably Well

Xylem Is A Good Buy At The Current Levels

Aug 18

When Should You Buy Xylem Inc. (NYSE:XYL)?

Aug 04
When Should You Buy Xylem Inc. (NYSE:XYL)?

Is Xylem (NYSE:XYL) Using Too Much Debt?

Jun 09
Is Xylem (NYSE:XYL) Using Too Much Debt?

Xylem: A Pure Water Play

Jun 09

Calculating The Intrinsic Value Of Xylem Inc. (NYSE:XYL)

May 09
Calculating The Intrinsic Value Of Xylem Inc. (NYSE:XYL)

Returns On Capital Signal Difficult Times Ahead For Xylem (NYSE:XYL)

Apr 24
Returns On Capital Signal Difficult Times Ahead For Xylem (NYSE:XYL)

Should You Think About Buying Xylem Inc. (NYSE:XYL) Now?

Apr 09
Should You Think About Buying Xylem Inc. (NYSE:XYL) Now?

Gewinn- und Umsatzwachstumsprognosen

NYSE:XYL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20269,5381,1601,2611,74513
12/31/20259,0401,0081,1541,57920
12/31/20248,5798031,0181,38620
6/30/20248,3967658901,205N/A
3/31/20247,949663649945N/A
12/31/20237,364609566837N/A
9/30/20236,752492507744N/A
6/30/20236,056352357573N/A
3/31/20235,698372450658N/A
12/31/20225,522355388596N/A
9/30/20225,339319225454N/A
6/30/20225,224421141364N/A
3/31/20225,211422265483N/A
12/31/20215,195427330538N/A
9/30/20215,245462514688N/A
6/30/20215,200385683851N/A
3/31/20215,009303629800N/A
12/31/20204,876254641824N/A
9/30/20204,874224655842N/A
6/30/20204,950252620812N/A
3/31/20205,135360546754N/A
12/31/20195,249401613839N/A
9/30/20195,264508408649N/A
6/30/20195,255573336591N/A
3/31/20195,227549361606N/A
12/31/20185,207549349586N/A
9/30/20185,098395473695N/A
6/30/20185,006370532736N/A
3/31/20184,853354N/A697N/A
12/31/20174,707331N/A686N/A
9/30/20174,525310N/A602N/A
6/30/20174,227278N/A523N/A
3/31/20173,995250N/A508N/A
12/31/20163,771260N/A497N/A
9/30/20163,670324N/A478N/A
6/30/20163,675339N/A466N/A
3/31/20163,663342N/A466N/A
12/31/20153,653340N/A464N/A
9/30/20153,701322N/A423N/A
6/30/20153,762340N/A441N/A
3/31/20153,847352N/A433N/A
12/31/20143,916337N/A416N/A
9/30/20143,907309N/A414N/A
6/30/20143,909276N/A360N/A
3/31/20143,864236N/A326N/A
12/31/20133,837228N/A324N/A
9/30/20133,773233N/A329N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: XYLDas prognostizierte Gewinnwachstum (15.9% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: XYLDie Erträge des Unternehmens (14.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.9% pro Jahr).

Hohe Wachstumserträge: XYLDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: XYLDie Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: XYLDie Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: XYLDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.8%).


Wachstumsunternehmen entdecken